Science 29 July 1977: Vol. 197. no. 4302, pp. 461 - 463 DOI: 10.1126/science.560061

Prev | Table of Contents | Next

Articles

Requirement of Arsenic Biomethylation for Oxidative DNA Damage.

C. Kojima, D. C. Ramirez, E. J. Tokar, S. Himeno, Z. Drobna, M. Styblo, R. P. Mason, and M. P. Waalkes (2009)
J Natl Cancer Inst
 |  Abstract »  |  Full Text »  |  PDF »

Evidence for Cancer Stem Cells in Human Endometrial Carcinoma.

S. A. Hubbard, A. M. Friel, B. Kumar, L. Zhang, B. R. Rueda, and C. E. Gargett (2009)
Cancer Res. 69, 8241-8248
 |  Abstract »  |  Full Text »  |  PDF »

Adenosine Triphosphate-based Chemotherapy Response Assay (ATP-CRA)-guided versus Empirical Chemotherapy in Unresectable Non-small Cell Lung Cancer.

Y. W. MOON, J. H. SOHN, Y. T. KIM, H. CHANG, J. H. JEONG, Y. J. LEE, J. CHANG, S. K. KIM, M. JUNG, S. HONG, et al. (2009)
Anticancer Res 29, 4243-4249
 |  Abstract »  |  Full Text »  |  PDF »

Role of Schlafen 2 (SLFN2) in the Generation of Interferon {alpha}-induced Growth Inhibitory Responses.

E. Katsoulidis, N. Carayol, J. Woodard, I. Konieczna, B. Majchrzak-Kita, A. Jordan, A. Sassano, E. A. Eklund, E. N. Fish, and L. C. Platanias (2009)
J. Biol. Chem. 284, 25051-25064
 |  Abstract »  |  Full Text »  |  PDF »

Expression of an Exogenous Human Oct-4 Promoter Identifies Tumor-Initiating Cells in Osteosarcoma.

P. P. Levings, S. V. McGarry, T. P. Currie, D. M. Nickerson, S. McClellan, S. C. Ghivizzani, D. A. Steindler, and C. P. Gibbs (2009)
Cancer Res. 69, 5648-5655
 |  Abstract »  |  Full Text »  |  PDF »

Stem cell concepts renew cancer research.

J. E. Dick (2008)
Blood 112, 4793-4807
 |  Abstract »  |  Full Text »  |  PDF »

Inflammation and Stem Cells in Gastrointestinal Carcinogenesis.

M. Quante and T. C. Wang (2008)
Physiology 23, 350-359
 |  Abstract »  |  Full Text »  |  PDF »

Mesothelin-Induced Pancreatic Cancer Cell Proliferation Involves Alteration of Cyclin E via Activation of Signal Transducer and Activator of Transcription Protein 3.

U. Bharadwaj, M. Li, C. Chen, and Q. Yao (2008)
Mol. Cancer Res. 6, 1755-1765
 |  Abstract »  |  Full Text »  |  PDF »

Myeloma Therapy: 25 Years Forward--Immune Modulation Then and Now.

B. G.M. Durie (2008)
J. Clin. Oncol. 26, 4698-4700
 |  Full Text »  |  PDF »

Cancer Stem Cells: A Step Toward the Cure.

B. M. Boman and M. S. Wicha (2008)
J. Clin. Oncol. 26, 2795-2799
 |  Full Text »  |  PDF »

Mathematical Models of Cancer Stem Cells.

F. Michor (2008)
J. Clin. Oncol. 26, 2854-2861
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Myeloma Cancer Stem Cells.

C. A. Huff and W. Matsui (2008)
J. Clin. Oncol. 26, 2895-2900
 |  Abstract »  |  Full Text »  |  PDF »

Temozolomide-Mediated Radiosensitization of Human Glioma Cells in a Zebrafish Embryonic System.

G. A. Geiger, W. Fu, and G. D. Kao (2008)
Cancer Res. 68, 3396-3404
 |  Abstract »  |  Full Text »  |  PDF »

Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells.

P. B Dirks (2008)
Phil Trans R Soc B 363, 139-152
 |  Abstract »  |  Full Text »  |  PDF »

Clonogenic Multiple Myeloma Progenitors, Stem Cell Properties, and Drug Resistance.

W. Matsui, Q. Wang, J. P. Barber, S. Brennan, B. D. Smith, I. Borrello, I. McNiece, L. Lin, R. F. Ambinder, C. Peacock, et al. (2008)
Cancer Res. 68, 190-197
 |  Abstract »  |  Full Text »  |  PDF »

A High-Throughput Soft Agar Assay for Identification of Anticancer Compound.

S. N. Anderson, D. L. Towne, D. J. Burns, and U. Warrior (2007)
J Biomol Screen 12, 938-945
 |  Abstract »  |  PDF »

Optimizing the development of targeted agents in pancreatic cancer: tumor fine-needle aspiration biopsy as a platform for novel prospective ex vivo drug sensitivity assays.

B. Rubio-Viqueira, H. Mezzadra, M. E. Nielsen, A. Jimeno, X. Zhang, C. Iacobuzio-Donahue, A. Maitra, M. Hidalgo, and S. Altiok (2007)
Mol. Cancer Ther. 6, 515-523
 |  Abstract »  |  Full Text »  |  PDF »

Bmi-1 Regulates the Differentiation and Clonogenic Self-renewal of I-type Neuroblastoma Cells in a Concentration-dependent Manner.

H. Cui, J. Ma, J. Ding, T. Li, G. Alam, and H.-F. Ding (2006)
J. Biol. Chem. 281, 34696-34704
 |  Abstract »  |  Full Text »  |  PDF »

Cancer stem cells..

C. T. Jordan, M. L. Guzman, and M. Noble (2006)
N. Engl. J. Med. 355, 1253-1261
 |  Full Text »  |  PDF »

The Biological Role of the Low-Affinity p75 Neurotrophin Receptor in Esophageal Squamous Cell Carcinoma.

T. Okumura, S. Tsunoda, Y. Mori, T. Ito, K. Kikuchi, T. C. Wang, S. Yasumoto, and Y. Shimada (2006)
Clin. Cancer Res. 12, 5096-5103
 |  Abstract »  |  Full Text »  |  PDF »

Notch Pathway Inhibition Depletes Stem-like Cells and Blocks Engraftment in Embryonal Brain Tumors..

X. Fan, W. Matsui, L. Khaki, D. Stearns, J. Chun, Y.-M. Li, and C. G. Eberhart (2006)
Cancer Res. 66, 7445-7452
 |  Abstract »  |  Full Text »  |  PDF »

CANCER STEM CELLS: Redefining the Paradigm of Cancer Treatment Strategies.

M. Dean (2006)
Mol. Interv. 6, 140-148
 |  Abstract »  |  Full Text »  |  PDF »

Prospective Identification of Tumorigenic Prostate Cancer Stem Cells.

A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland (2005)
Cancer Res. 65, 10946-10951
 |  Abstract »  |  Full Text »  |  PDF »

Pharmacodynamics of the G-Quadruplex-Stabilizing Telomerase Inhibitor 3,11-Difluoro-6,8,13-trimethyl-8H-quino[4,3,2-kl]acridinium methosulfate (RHPS4) in Vitro: Activity in Human Tumor Cells Correlates with Telomere Length and Can Be Enhanced, or Antagonized, with Cytotoxic Agents.

J. C. Cookson, F. Dai, V. Smith, R. A. Heald, C. A. Laughton, M. F. G. Stevens, and A. M. Burger (2005)
Mol. Pharmacol. 68, 1551-1558
 |  Abstract »  |  Full Text »  |  PDF »

Retention of Intrinsic Stem Cell Hierarchies in Carcinoma-Derived Cell Lines.

M. Locke, M. Heywood, S. Fawell, and I. C. Mackenzie (2005)
Cancer Res. 65, 8944-8950
 |  Abstract »  |  Full Text »  |  PDF »

Neural Stem Cells and the Origin of Gliomas.

N. Sanai, A. Alvarez-Buylla, and M. S. Berger (2005)
N. Engl. J. Med. 353, 811-822
 |  Full Text »  |  PDF »

Overexpression of Cyclin D1 Promotes Tumor Cell Growth and Confers Resistance to Cisplatin-Mediated Apoptosis in an Elastase-myc Transgene-Expressing Pancreatic Tumor Cell Line.

H. Biliran Jr., Y. Wang, S. Banerjee, H. Xu, H. Heng, A. Thakur, A. Bollig, F. H. Sarkar, and J. D. Liao (2005)
Clin. Cancer Res. 11, 6075-6086
 |  Abstract »  |  Full Text »  |  PDF »

Multiple Drug Resistance in Cancer Revisited: The Cancer Stem Cell Hypothesis.

V. S. Donnenberg and A. D. Donnenberg (2005)
J. Clin. Pharmacol. 45, 872-877
 |  Abstract »  |  Full Text »  |  PDF »

Micrometastases in neuroblastoma: are they clinically important?.

S A Burchill (2004)
J. Clin. Pathol. 57, 14-20
 |  Abstract »  |  Full Text »  |  PDF »

Eye-Preservation Treatment of Retinoblastoma with Vitreous Seeding.

A. Kaneko and S. Suzuki (2003)
Jpn. J. Clin. Oncol. 33, 601-607
 |  Abstract »  |  Full Text »  |  PDF »

An Overview of Stem Cell Research and Regulatory Issues.

C. R. Cogle, S. M. Guthrie, R. C. Sanders, W. L. Allen, E. W. Scott, and B. E. Petersen (2003)
Mayo Clin. Proc. 78, 993-1003
 |  Abstract »  |  PDF »

From the Cover: Prospective identification of tumorigenic breast cancer cells.

M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke (2003)
PNAS 100, 3983-3988
 |  Abstract »  |  Full Text »  |  PDF »

Predicting Tumor Responses to Mitomycin C on the Basis of DT-Diaphorase Activity or Drug Metabolism by Tumor Homogenates: Implications for Enzyme-directed Bioreductive Drug Development.

R. M. Phillips, A. M. Burger, P. M. Loadman, C. M. Jarrett, D. J. Swaine, and H.-H. Fiebig (2000)
Cancer Res. 60, 6384-6390
 |  Abstract »  |  Full Text »

Cooperation of bcl-2 and myc in the neoplastic transformation of normal rat liver epithelial cells is related to the down-regulation of gap junction-mediated intercellular communication.

N. D. DeoCampo, M. R. Wilson, and J. E. Trosko (2000)
Carcinogenesis 21, 1501-1506
 |  Abstract »  |  Full Text »  |  PDF »

Reduced levels of connexin43 in cervical dysplasia: inducible expression in a cervical carcinoma cell line decreases neoplastic potential with implications for tumor progression.

T. J. King, L. H. Fukushima, A. D. Hieber, K. A. Shimabukuro, W. A. Sakr, and J. S. Bertram (2000)
Carcinogenesis 21, 1097-1109
 |  Abstract »  |  Full Text »  |  PDF »

Suppression of Tumorigenicity in Breast Cancer Cells by the Microfilament Protein Profilin 1.

J. Janke, K. Schluter, B. Jandrig, M. Theile, K. Kolble, W. Arnold, E. Grinstein, A. Schwartz, L. Estevez-Schwarz, P. M. Schlag, et al. (2000)
J. Exp. Med. 191, 1675-1686
 |  Abstract »  |  Full Text »  |  PDF »

Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS.

P. T. Masiakos, D. T. MacLaughlin, S. Maheswaran, J. Teixeira, A. F. Fuller Jr., P. C. Shah, D. J. Kehas, M. K. Kenneally, D. M. Dombkowski, T. U. Ha, et al. (1999)
Clin. Cancer Res. 5, 3488-3499
 |  Abstract »  |  Full Text »  |  PDF »

Transcriptional Regulation of Rat Cyclin D1 Gene by CpG Methylation Status in Promoter Region.

S. Kitazawa, R. Kitazawa, and S. Maeda (1999)
J. Biol. Chem. 274, 28787-28793
 |  Abstract »  |  Full Text »  |  PDF »

Review of the Efficacy of Individualized Chemotherapy Selected by In Vitro Drug Sensitivity Testing for Patients With Cancer.

P. Cortazar and B. E. Johnson (1999)
J. Clin. Oncol. 17, 1625
 |  Abstract »  |  Full Text »  |  PDF »

Drug Response of Head and Neck Tumors in Native-State Histoculture.

K. T. Robbins, N. M. Varki, A. M. Storniolo, H. Hoffman, and R. M. Hoffman (1991)
Arch Otolaryngol Head Neck Surg 117, 83-86
 |  Abstract »  |  PDF »

Amino Acid Requirements of a Rat Sarcoma as Determined by a Stem Cell Assay.

T. J. Miller, R. S. Franco, W. T. Chance, O. J. Martelo, and M. B. Popp (1987)
JPEN J Parenter Enteral Nutr 11, 223-228
 |  Abstract »  |  PDF »

Immunomodulation of Nodal Lymphocytes in Head and Neck Cancer.

D. E. Schuller, D. H. Libby, J. J. Rinehart, G. G. Milo, and A. Koolemans-Beynen (1985)
Arch Otolaryngol Head Neck Surg 111, 465-468
 |  Abstract »  |  PDF »

Colony-Forming Assay of Human Salivary Gland Tumors: Applications for Chemosensitivity and Histogenetic Studies.

M. E. Johns, S. E. Mills, and K. K. Thompson (1983)
Arch Otolaryngol Head Neck Surg 109, 709-714
 |  Abstract »  |  PDF »

Human Tumor Cloning Assay in Advanced Head and Neck Cancer: Prospective Correlative Trial.

D. E. Mattox, D. D. Von Hoff, and L. L. Harris (1983)
Arch Otolaryngol Head Neck Surg 109, 724-726
 |  Abstract »  |  PDF »

Biopsy of Thoracic Neoplasms for Assay of Chemosensitivity: New Indication for Thoracotomy.

C. A. Bertelsen, D. H. Kern, L. R. Kaiser, B. D. Mann, E. C. Holmes, and D. L. Morton (1983)
Arch Surg 118, 1074-1076
 |  Abstract »  |  PDF »

The Role of the Human Tumor Stem Cell Assay in Medical Oncology.

P. A. Johnson and A. H. Rossof (1983)
Arch Intern Med 143, 111-114
 |  Abstract »  |  PDF »

Neuroblastoma: Clinical Perspectives, Monoclonal Antibodies, and Retinoic Acid.

R. C. SEEGER, S. E. SIEGEL, and N. SIDELL (1982)
Ann Intern Med 97, 873-884
 |  Abstract »  |  PDF »

Clinical Correlations With Drug Sensitivities in the Clonogenic Assay: A Retrospective Study.

B. D. Mann, D. H. Kern, A. E. Giuliano, M. W. Burk, M. A. Campbell, L. R. Kaiser, and D. L. Morton (1982)
Arch Surg 117, 33-36
 |  Abstract »  |  PDF »

Culture of Human Head and Neck Cancer Stem Cells Using Soft Agar.

D. E. Mattox and D. D. Von Hoff (1980)
Arch Otolaryngol Head Neck Surg 106, 672-674
 |  Abstract »  |  PDF »

To Advertise   |   Find Products